ICAP, in partnership with the Ministry of Health and the Family Life Association of Swaziland, provided support to establish a clinical trial unit, where the HIV Prevention Trials Network (HPTN) Protocol 084 is being implemented. HPTN 084 is a multi-country, multi-site, randomized controlled clinical trial exploring the safety and efficacy of long-acting injectable cabotegravir compared to daily oral tenofovir dispoproxil fumarate/emtricitabine for pre-exposure prophylaxis (PrEP) in HIV-uninfected women. Find out more on the HPTN Page